0
A study raises the possibility that a common sweetener could suppress T-cell activation in humans, leading to potential therapeutic applications for managing diseases where excessive T-cell activation is problematic.
0
Why low-cost ketamine is still inaccessible to many with severe depression A case study on ketamine reveals systemic barriers that prevent repurposing existing low-cost drugs like ketamine for treatment-resistant depression. Patient ...
0
This study reports the creation of a model thermodynamic engine that is fuelled by the energy difference resulting from changing the statistics of a quantum gas from bosonic to fermionic.
0
Largest replication study to date casts doubt on many published positive results.
0
Researchers assessed whether a short course of induction chemotherapy before chemoradiation could reduce rates of relapse and death.
0
Trial involved short course of induction chemotherapy before standard chemoradiation treatment
0
Bats are natural reservoir hosts for viruses that cause higher case fatality rates in humans than do zoonoses derived from any other source. This study builds a nested within-host, population-level model to offer a mechanistic explanation for this ph ...
0
A new U of A study suggests many women in Alberta use cannabis to treat symptoms that may be due to menopause despite a lack of evidence that it is effective for menopause symptoms, highlighting issues with menopause care for women seeking treatment ...
0
The study marks the first time researchers have been able to “visualize plant-to-plant communication,” the senior author of the study said.
0
A new study by Australian researchers has shown that fluctuating blood pressure can increase the risk of dementia and vascular problems in older people.
0
Researchers have developed an AI focused on improving the reliability of Wikipedia references.